Compare ELVN & PAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ELVN | PAM |
|---|---|---|
| Founded | 2016 | 1945 |
| Country | United States | Argentina |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 4.5B |
| IPO Year | 2020 | 2009 |
| Metric | ELVN | PAM |
|---|---|---|
| Price | $41.41 | $79.60 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 11 |
| Target Price | $73.92 | ★ $121.09 |
| AVG Volume (30 Days) | ★ 1.2M | 139.4K |
| Earning Date | 11-11-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.17 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $41.82 |
| Revenue Next Year | N/A | $14.13 |
| P/E Ratio | ★ N/A | $13.79 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.79 | $69.34 |
| 52 Week High | $62.32 | $94.50 |
| Indicator | ELVN | PAM |
|---|---|---|
| Relative Strength Index (RSI) | 39.47 | 47.66 |
| Support Level | $37.77 | $78.16 |
| Resistance Level | $43.05 | $83.56 |
| Average True Range (ATR) | 1.84 | 2.14 |
| MACD | 0.57 | -0.04 |
| Stochastic Oscillator | 50.69 | 52.99 |
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
Pampa Energia SA and its subsidiaries are engaged in the Energy business, mainly in oil and gas production and power generation. The firm's operating business segments are Oil and Gas, Generation, Petrochemicals, Holding, Transportation, and Others. The company derives the maximum revenue from the oil and gas segment.